HTG Molecular Diagnostics: Q2 Earnings Insights



HTG Molecular Diagnostics HTGM reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.


HTG Molecular Diagnostics beat estimated earnings by 10.0%, reporting an EPS of $-0.54 versus an estimate of $-0.6.

Revenue was down $582 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 0.34% increase in the share price the next day.

Here’s a look at HTG Molecular Diagnostics’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.71 -0.59 -0.66 -0.77
EPS Actual -0.81 -0.69 -0.60 -0.65
Revenue Estimate 2.15M 2.97M 2.65M 2.13M
Revenue Actual 1.18M 2.88M 2.52M 2.07M

To track all earnings releases for HTG Molecular Diagnostics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


Image and article originally from Read the original article here.